Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers - Wikidata - awgldk - TriplyDB

Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers

Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers

http://www.wikidata.org/entity/Q26822406

about

Pancreatic cancer stem cell markers and exosomes - the incentive push MicroRNA Regulation of Epithelial to Mesenchymal Transition Cancer stem cells and exosome signaling Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow.LXY6090 - a novel manassantin A derivative - limits breast cancer growth through hypoxia-inducible factor-1 inhibition Persistence of CD34 Stem Marker in Human Lipoma: Searching for Cancer Stem Cells.Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes.Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma.LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway Circulating biomarkers for gliomas.Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway.Human pancreatic cancer progression: an anarchy among CCN-siblings.Beyond cell-cell adhesion: Plakoglobin and the regulation of tumorigenesis and metastasis High CD133 Expression Is Associated with Worse Prognosis in Patients with Glioblastoma.Prognostic impact of CD133 expression in Endometrial Cancer Patients.Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence.Exosomes Regulate the Transformation of Cancer Cells in Cancer Stem Cell Homeostasis

P2860

Q26741215-F9C51EC1-ED16-4CD4-B703-93BDF3C88705 Q26771110-1970C57A-646F-411D-B827-F0C2EC5A20B2 Q27013625-CE34394B-DB7C-4E63-82CB-15416BFF35CB Q28552301-0556FB64-95A1-491F-AAB5-8BBE3BD2B9A5 Q28818141-2123C16B-900C-4934-9537-538581EF349C Q28828209-5446B32A-8261-4355-8B30-4C4FB889D38E Q36002070-2645502C-19ED-41A2-A54B-20817B9BA77B Q36165598-4BEA5E9F-6AC5-4D07-B02A-3D68F2BE33E5 Q36320483-EE9116AA-31C2-436B-85F8-86DA22C1E04F Q36638387-D08816EB-176A-4828-B1D8-AC116CA5321A Q36651307-9CE604EC-FA8C-4DCE-9387-D5F4B28DA704 Q36799399-B5D32900-38AE-4420-B1D1-9E899D249B79 Q38586617-110798BA-54E5-4506-A8A6-DF6BF3F3FE83 Q38655417-8F1D320A-1D22-4132-A87D-8192ABAC2C6A Q38931858-87C0BE21-C610-4975-8E11-3FE9BE0FAC0F Q39247115-74646B3A-9507-4C5D-9B25-62247067F9EF Q40930271-01070EB9-B5D7-44E5-A0C2-D91F4579AAAA Q41332330-EF9B8F5F-D55A-40CD-B402-8C58F133DCA8 Q48228203-E3B77DE9-1C36-49D4-8B27-556DFA284E9A Q57821810-D12B6D6A-BBB7-44B8-BABF-5A71F69D6349

P2860

Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers

http://www.wikidata.org/entity/Q26822406

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@ast

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@en

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@nl

type

label

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@ast

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@en

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@nl

prefLabel

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@ast

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@en

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@nl

P1433

Q26822406-08CFF12C-25CF-4750-9EB4-13C2879703D2

P1476

Q26822406-3B8357F0-B8CF-4632-9662-CAE07A9B8BBE

P2093

Q26822406-7B5DB6BC-BE31-4071-B2E1-3E7A6482014C

Q26822406-8965F399-0597-43FC-B260-DC7E33D8BFE0

P2860

Q26822406-010C779B-A9C4-4CF5-820F-AFD7BEBED624

Q26822406-02946348-F21B-47D1-998C-8A628A621661

Q26822406-033944DB-7C3F-4B90-B759-FF1DF08416CB

Q26822406-057F3309-86B5-4F81-BFBB-CF57E746AC56

Q26822406-0656B64F-2FD5-4D03-92B1-E445A833616E

Q26822406-080D5C05-FC09-44EC-BBCC-D1AA576A087D

Q26822406-0AF29961-2FE0-470F-95E0-C81BBF6694A1

Q26822406-0C8622F1-BA30-4C21-9CFB-DAF7DB26849F

Q26822406-0D56CA83-5DFB-4579-8B8E-8B16F93DB090

Q26822406-0D9DA2AB-D1D4-4D5A-B1F1-6069D966882E

P304

Q26822406-B1846EA1-E14F-45A3-A52D-852A24D3E35D

P31

Q26822406-A2D1CDF0-DF86-44A6-B0A4-3511F66D3B76

P3181

Q26822406-3AAD0078-E1D8-4A48-8755-701C941DF568

P356

Q26822406-46A668A2-DD08-4519-BF65-ABEE6EE41433

P407

Q26822406-BEC3A229-93CA-46D8-9428-0D8917F3D170

P433

Q26822406-314711F2-3315-452B-B746-FEEE44BF7D3F

P478

Q26822406-50E1DF2D-1CF9-4644-A960-68FF42D22CB6

P577

Q26822406-E75B6770-C41D-4B89-8F98-FB936E76CDDD

P698

Q26822406-B64E268A-AF36-4CD6-BAC4-AC6ADB57E93B

P921

Q26822406-CB9753FB-5F2D-452A-8905-4B664F505799

P932

Q26822406-C339BA03-A217-4990-AE37-697C7B19DFAD

P3181

P356

1055-9965.EPI-13-0785

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Molecular biomarkers of cancer ...... sistance of aggressive cancers

@en

P2093

M. Mimeault

http://www.w3.org/2001/XMLSchema#string

S. K. Batra

http://www.w3.org/2001/XMLSchema#string

P2860

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits

Rab27a and Rab27b control different steps of the exosome secretion pathway

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

Cancerous stem cells can arise from pediatric brain tumors

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer

P304

234-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

324588

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1055-9965.EPI-13-0785

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24273063

http://www.w3.org/2001/XMLSchema#string

P921

P932

3977531

http://www.w3.org/2001/XMLSchema#string